<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Sitruk-Ware, Regine</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Oral Contraceptives and CV Health</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">30-31</style></pages><abstract><style  face="normal" font="default" size="100%">Oral contraceptives are the most commonly used form of birth control worldwide [Blackmore KM et al. BMC Womens Health 2011]. Estrogen and progestins have been used by millions of women as effective combined oral contraceptives. Their safety has been documented by years of follow-up, and serious adverse events that may be related to their use are rare in the young population that is exposed to these agents.</style></abstract><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>